Search

everythinglearnresearchcommunity

for

Search:↓

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Early hair loss may indicate prostate issues.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Annurca apple supplement safely increases hair growth and keratin in humans.